GUIDUCCI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.104
EU - Europa 19.411
AS - Asia 14.485
SA - Sud America 1.953
Continente sconosciuto - Info sul continente non disponibili 531
AF - Africa 448
OC - Oceania 255
Totale 63.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.501
IT - Italia 5.883
RU - Federazione Russa 5.604
SG - Singapore 3.978
CN - Cina 3.589
PL - Polonia 2.740
HK - Hong Kong 2.008
BR - Brasile 1.504
VN - Vietnam 1.456
KR - Corea 1.285
IE - Irlanda 1.216
SE - Svezia 937
FI - Finlandia 647
FR - Francia 609
DE - Germania 544
IN - India 487
BD - Bangladesh 457
CA - Canada 370
NL - Olanda 340
GB - Regno Unito 318
JP - Giappone 280
AU - Australia 247
TR - Turchia 192
ID - Indonesia 165
UA - Ucraina 156
AR - Argentina 155
JO - Giordania 150
ES - Italia 111
MX - Messico 98
IQ - Iraq 97
CI - Costa d'Avorio 86
CH - Svizzera 80
EC - Ecuador 70
ZA - Sudafrica 69
CO - Colombia 59
MA - Marocco 55
NG - Nigeria 46
VE - Venezuela 43
EG - Egitto 41
PK - Pakistan 40
PH - Filippine 38
AE - Emirati Arabi Uniti 33
BJ - Benin 32
CL - Cile 30
AT - Austria 28
LT - Lituania 27
PE - Perù 26
UZ - Uzbekistan 26
TN - Tunisia 24
JM - Giamaica 23
KE - Kenya 23
SA - Arabia Saudita 22
UY - Uruguay 22
BE - Belgio 21
BO - Bolivia 21
AZ - Azerbaigian 20
CR - Costa Rica 19
PY - Paraguay 19
RO - Romania 19
IL - Israele 18
KZ - Kazakistan 17
MY - Malesia 16
HN - Honduras 15
PT - Portogallo 14
DZ - Algeria 13
IR - Iran 13
LV - Lettonia 13
CZ - Repubblica Ceca 12
ET - Etiopia 12
EU - Europa 12
TW - Taiwan 12
AL - Albania 11
DO - Repubblica Dominicana 11
NP - Nepal 11
RS - Serbia 11
GT - Guatemala 10
HU - Ungheria 10
TT - Trinidad e Tobago 10
GE - Georgia 9
OM - Oman 9
PR - Porto Rico 9
SC - Seychelles 9
SN - Senegal 9
SV - El Salvador 9
TH - Thailandia 9
BY - Bielorussia 8
NO - Norvegia 8
PA - Panama 8
BG - Bulgaria 7
NZ - Nuova Zelanda 7
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
GR - Grecia 6
LB - Libano 6
NI - Nicaragua 6
BB - Barbados 5
CM - Camerun 5
DK - Danimarca 5
KH - Cambogia 5
SK - Slovacchia (Repubblica Slovacca) 5
Totale 62.583
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.602
Ashburn 3.256
Singapore 2.932
Warsaw 2.711
Fairfield 2.208
Hong Kong 1.675
Seoul 1.254
Dublin 1.203
Chandler 1.186
Woodbridge 1.025
Hefei 933
Seattle 926
San Jose 897
Cambridge 869
Milan 861
Houston 809
Wilmington 688
Beijing 649
Florence 566
Rome 553
Ho Chi Minh City 477
Los Angeles 417
Buffalo 378
Lauterbourg 367
Princeton 347
Lawrence 345
Altamura 340
The Dalles 317
Hanoi 313
Ann Arbor 298
Jacksonville 272
Helsinki 255
New York 255
Moscow 247
Council Bluffs 246
Mumbai 237
Melbourne 231
Boston 229
Tokyo 222
Munich 208
Boardman 191
Naples 181
Dallas 169
Medford 155
Turin 147
Shanghai 133
São Paulo 133
San Diego 131
Kent 129
Paris 122
Amsterdam 118
Jakarta 114
Chicago 113
Bologna 99
Montreal 90
Abidjan 86
Turku 86
Toronto 80
Izmir 78
Falls Church 75
Orem 72
Clifton 69
London 69
Norwalk 65
Bari 64
Da Nang 63
Frankfurt am Main 63
Pune 63
Haiphong 59
Redondo Beach 58
Catania 57
Palermo 56
Lappeenranta 55
Dong Ket 52
Figino 52
Phoenix 52
Brooklyn 51
Genoa 51
Yubileyny 50
Bengaluru 49
Bern 47
Abuja 45
Johannesburg 45
Guangzhou 44
Atlanta 43
Hillsboro 43
Rio de Janeiro 43
West Jordan 43
Chennai 42
Baghdad 41
Venice 41
Cagliari 39
Tianjin 38
Verona 38
Belo Horizonte 36
Brescia 36
Denver 36
Mexico City 35
Barcelona 34
Padua 34
Totale 40.207
Salva come PNG Salva come JPEG
Nome #
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 1.847
Systemic sclerosis: one year in review 2024 384
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 373
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 359
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 344
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 344
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 332
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 331
[Peripheral nervous system in limited systemic sclerosis]. 331
[The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases]. 330
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 313
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. 312
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. 305
Allostatic overload in the medically ill patients: Results from an observational study 299
The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem? 297
Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes 289
Circulating Calprotectin (cCLP) in autoimmune diseases 288
Interstitial lung disease in systemic sclerosis: Where do we stand? 284
[Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis]. 283
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 281
Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide 278
Sintomatologia gastrointestinale e qualità di vita dei pazienti affetti da Sclerosi Sistemica 271
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 268
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 262
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 262
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 249
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 244
High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis. 244
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 243
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 242
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 241
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 240
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 237
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. 235
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 233
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis 233
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 228
A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis 228
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 216
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 215
Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice 211
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 211
Ultrasound-detected bilateral subacromial-subdeltoid bursitis exceeding 3 mm differentiates polymyalgia rheumatica from rotator cuff tendinopathy: a cross-sectional observational study 208
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 207
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 207
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 207
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. 206
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 206
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 206
The Role of Adipokines between Genders in the Pathogenesis of Osteoarthritis 205
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 204
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 204
Severe fibrotic changes and altered expression of angiogenic factors in maternal scleroderma: placental findings. 203
Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group 198
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 198
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 198
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview 197
Mental Pain Questionnaire: Clinimetric Properties of a Potential Global Person‐Centred Outcome Measure 196
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report 196
Calcinosis in systemic sclerosis: subsets, distribution and complications 196
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 194
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 193
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 192
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 191
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. 191
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 191
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. 191
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 191
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 190
What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review 190
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 190
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 189
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 188
I SINOVIOCITI DI ARTRITE REUMATOIDE (AR) PRESENTANO IL PATTERN FIBRINOLITICO DELLE CELLULE INVASIVE. REUMATISMO, 2001 VOL 53 N°3 (SUPPL. N° 4) 188
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 186
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 186
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 185
A systematic review of the literature on nursing sensitive outcomes in scleroderma: towards a structured path led by a nurse case manager 185
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 184
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 184
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 183
Stiff skin syndrome: evidence for an inflammation-independent fibrosis? 182
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 182
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 182
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. 182
Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. 180
Angiotensin-converting enzyme in systemic sclerosis: from endothelial injury to a genetic polymorphism. 180
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 180
Influence of gender on Behçet's Disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 179
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 178
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative 178
Systemic Sclerosis Association with Malignancy 177
MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN 177
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis 177
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association? 176
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 176
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 175
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 175
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 175
Totale 24.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 176.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.974 0 182 164 86 91 123 61 155 139 73 267 633
2022/20235.204 555 978 176 373 387 915 668 252 507 97 178 118
2023/20243.038 86 274 450 160 211 387 155 515 88 292 259 161
2024/202517.158 634 1.728 1.028 2.506 4.230 1.862 647 1.215 1.001 608 800 899
2025/202622.661 2.279 2.943 2.203 1.791 2.278 849 2.497 1.138 1.565 1.341 1.063 2.714
2026/20271.293 1.052 241 0 0 0 0 0 0 0 0 0 0
Totale 63.187